2021 Course Highlights




  • New FDA guidelines for naloxone use
  • Treating acute and chronic pain in patients with substance use disorder 
  • Managing complicated alcohol withdrawal
  • Alcoholic hallucinosis in the inpatient setting: is haloperidol safe?
  • Reducing the risk of recurrent opiate overdose at discharge



  • What to do when there is no allergist
  • Penicillin allergy: a risk factor for inferior antibiotic treatment
  • Getting rid of the low-risk penicillin allergy label 
  • New anaphylaxis guidelines



  • Dual anti-platelet therapy after stenting: are we overdoing it?
  • Rethinking rhythm control versus rate control for atrial fibrillation
  • Peri-operative anticoagulation in patients on DOACs
  • Post-op atrial fibrillation: to anticoagulate, or not to anticoagulate?
  • CHA₂DS₂-VASc: more than just a number?
  • SGLT-2 inhibitors: a new standard for CHF treatment
  • New data on the benefits of IV iron in heart failure
  • Overcoming diuretic resistance in heart failure
  • Is it ever OK to stop anticoagulation in unprovoked venous thrombosis?
  • When to refer patients with aortic stenosis for TAVR



  • Update on pharmacotherapy for delirium
  • Reducing delirium complications: is a bedside companion key?
  • Hospital-acquired delirium: a risk factor for dementia
  • Difficult cases in delirium management



  • Can't-miss ECG diagnoses
  • Radiology pearls: identifying subtle findings on CXR
  • Rapid-fire review of electrolyte, liver, and heme cases
  • Contrast or no contrast? Choosing the right imaging protocols



  • Hyperglycemia in the setting of COVID cytokine storm
  • Dangers of SGLT2 inhibitors: euglycemic DKA and UTIs
  • Challenging cases in insulin management
  • Best practices for hyperglycemic crises



  • COVID-19 and the GI tract
  • New risk scores for GI bleeding
  • Time to rethink the "GI cocktail?"
  • Urgent endoscopy in acute GI bleeding: bad for patients?
  • Managing bleeding and thrombosis in the cirrhotic patient
  • Too soon? Resuming anticoagulation and antiplatelet agents after a GI bleed
  • New data on the management of upper GI bleeding



  • DOACs for cancer-associated venous thrombosis
  • DOAC use in obesity and kidney disease
  • Diagnosing and managing thrombocytopenia
  • Approach to anemia in the hospitalized patient
  • The latest on COVID-associated arterial and venous thrombosis



  • Long live the fecal microbiota transplant!
  • New strategies to prevent recurrent cellulitis
  • New antibiotics for MRSA and highly-resistant gram-negative rods
  • Are we underdosing beta-lactams in the critically ill?
  • The latest data on COVID-19 vaccines
  • Risks for COVID-19 in healthcare workers and their families
  • High rates of asymptomatic COVID-19 in nursing home patients
  • SARS-CoV-2 mutations: what are the clinical implications?
  • Corticosteroids in COVID-19
  • Evidence-based treatment for COVID-19: what actually works?
  • SARS-CoV-2 reinfection: what does it mean for hospitalists?
  • Intensive case-based review of inpatient antibiotic therapy
  • New antibiotics for complicated UTIs
  • Pearls for interpreting culture and sensitivity data



  • Palliative care in end-stage COPD
  • Alternatives to the 10-point pain scale
  • Case-based approach to the complex palliative care patient
  • What time is the right time to call palliative care?



  • Should we use BNP to predict perioperative risk?
  • The latest on perioperative aspirin, statins, beta-blockers, and ACE inhibitors
  • Perioperative anticoagulation: when should patients be bridged?
  • Timing of surgery in hip fracture patients
  • Reducing pulmonary risk in perioperative patients



  • Non-invasive ventilation in COPD: new guidelines
  • State of the art treatment for asthma and COPD exacerbations
  • Current recommendations for high-flow and supplemental O2
  • Are C-reactive protein and procalcitonin useful in COPD and pneumonia management?



  • Dapagliflozin and reduction of progression of chronic kidney disease
  • New data: early renal replacement therapy in acute kidney injury
  • COVID and acute kidney injury: what the hospitalist needs to know
  • Dialysis access: what the hospitalist needs to know
  • Blood pressure management in end-stage renal disease
  • The latest on managing hyperkalemia and hyperphosphatemia
  • Diagnosing acute kidney injury and acute glomerulonephritis



  • New AHA/ASA guidelines for stroke management
  • Updates on mechanical thrombectomy for ischemic stroke
  • The unexpected dangers of SSRIs in acute stroke
  • Anti-platelet therapy in stroke and TIA



  • Syncope: when to worry about cardiac causes
  • New recommendations for the use of tilt table testing
  • Syncope as a presenting symptom of COVID
  • Diagnosing the patient with recurrent syncope